Evaluation of the Visibility and Artifacts of 11 Common Fiducial Markers for Image Guided Stereotactic Body Radiation Therapy in the Abdomen-Reference-Cited by-同舟云学术

Evaluation of the Visibility and Artifacts of 11 Common Fiducial Markers for Image Guided Stereotactic Body Radiation Therapy in the Abdomen

Published:2020-11 Issue:6 Volume:10 Page:434-442
ISSN:1879-8500
Container-title:Practical Radiation Oncology
language:en
Short-container-title:Practical Radiation Oncology

Author:

Slagowski Jordan M.^ORCID,Colbert Lauren E.,Cazacu Irina M.,Singh Ben S.,Martin Rachael,Koay Eugene J.,Taniguchi Cullen M.,Koong Albert C.,Bhutani Manoop S.,Herman Joseph M.,Beddar Sam

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology

Reference18 articles.

1. Stereotactic body radiation therapy: The report of AAPM Task Group 101;Benedict;Med Phys,2010

2. Stereotactic body radiotherapy for oligometastases;Tree;Lancet Oncol,2013

3. Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell-lung cancer patients treated with stereotactic body radiotherapy;Baumann;J Clin Oncol,2009

4. Stereotactic body radiotherapy for unresected pancreatic cancer: A nationwide review;De Geus;Cancer,2017

5. The role or stereotactic body radiation therapy for pancreatic cancer: A single-institution experience;Moningi;Ann Surg Oncol,2015

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Minimum and optimal requirements for a safe clinical implementation of ultra-high dose rate radiotherapy: A focus on patient’s safety and radiation protection;Radiotherapy and Oncology;2024-07

2. A Novel Polymer-Encapsulated Multi-Imaging Modality Fiducial Marker with Positive Signal Contrast for Image-Guided Radiation Therapy;Cancers;2024-01-31

3. Endoscopic Ultrasound-Guided Fiducial Placement for Stereotactic Body Radiation Therapy in Patients with Pancreatic Cancer;Cancers;2023-11-10

4. Smart Radiotherapy Biomaterials for Image-Guided In Situ Cancer Vaccination;Nanomaterials;2023-06-12

5. Feasibility and guidelines for the use of an injectable fiducial marker (BioXmark®) to improve target delineation in preclinical radiotherapy studies using mouse models.;F1000Research;2023-05-22